Back
Rocket Pharmaceuticals Vs. Phathom Pharmaceuticals Industry Stock Comparison
Buy
53
RCKT
Rocket Pharmaceuticals
Last Price:
21.35
Seasonality Move:
40.59%
Buy
62
PHAT
Phathom Pharmaceuticals
Last Price:
18.71
Seasonality Move:
-9.67%
Buy
53
Rocket Pharmaceuticals (RCKT)
is a Buy
Is Rocket Pharmaceuticals a Buy, Sell or Hold?
- The current Rocket Pharmaceuticals [RCKT] share price is $20.84. The Score for RCKT is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
- RCKT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
62
Phathom Pharmaceuticals (PHAT)
is a Buy
Is Phathom Pharmaceuticals a Buy, Sell or Hold?
- The current Phathom Pharmaceuticals [PHAT] share price is $19.25. The Score for PHAT is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
- PHAT is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
RCKT Stock Price Chart
What is Rocket Pharmaceuticals's stock price today?
-
The Rocket Pharmaceuticals share price today is $20.84
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RCKT is experiencing selling pressure, which indicates risk of future bearish movement.
PHAT Stock Price Chart
What is Phathom Pharmaceuticals's stock price today?
-
The Phathom Pharmaceuticals share price today is $19.25
The current trend is moderately bullish and PHAT is experiencing buying pressure, which is a positive indicator for future bullish movement.
RCKT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.04 | Buy |
Relative Strength Index (14 RSI): | 56.57 | Buy |
Chaikin Money Flow: | -615815 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (18.27 - 19.97) | Buy |
Bollinger Bands (100): | (19.48 - 23.36) | Sell |
PHAT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.64 | Buy |
Relative Strength Index (14 RSI): | 71.51 | Buy |
Chaikin Money Flow: | 686596 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (13.56 - 18.4) | Buy |
Bollinger Bands (100): | (9.43 - 14.73) | Buy |
RCKT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 19.85 | Buy |
20-day SMA: | 19.18 | Buy |
50-day SMA: | 20.72 | Buy |
200-day SMA: | 24.45 | Sell |
8-day EMA: | 19.98 | Buy |
20-day EMA: | 19.6 | Buy |
50-day EMA: | 20.28 | Buy |
200-day EMA: | 22.24 | Sell |
PHAT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 18.58 | Buy |
20-day SMA: | 16.79 | Buy |
50-day SMA: | 13.77 | Buy |
200-day SMA: | 10.45 | Buy |
8-day EMA: | 18.47 | Buy |
20-day EMA: | 16.97 | Buy |
50-day EMA: | 14.61 | Buy |
200-day EMA: | 11.63 | Buy |
Rocket Pharmaceuticals Earnings Growth & RCKT Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.03 per share, an increase next quarter of $0.04 per share, an increase this year of $0.16 per share, and an increase next year of $0.25 per share.
Phathom Pharmaceuticals Earnings Growth & PHAT Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.50 per share, an increase next quarter of $0.54 per share, a decrease this year of $1.71 per share, and an increase next year of $1.35 per share.
Rocket Pharmaceuticals Technical Analysis
Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Phathom Pharmaceuticals Technical Analysis
Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |